BRAF G466V
|
CRC
|
BRAF G466V
|
CRC
|
trametinib Sensitive: C4 – Case Studies
|
trametinib Sensitive: C4 – Case Studies
|
BRAF G466V
|
CRC
|
BRAF G466V
|
CRC
|
vemurafenib Sensitive: C4 – Case Studies
|
vemurafenib Sensitive: C4 – Case Studies
|
BRAF G466V
|
CRC
|
BRAF G466V
|
CRC
|
cetuximab Sensitive: C4 – Case Studies
|
cetuximab Sensitive: C4 – Case Studies
|
BRAF G466V
|
CRC
|
BRAF G466V
|
CRC
|
panitumumab Sensitive: C4 – Case Studies
|
panitumumab Sensitive: C4 – Case Studies
|